Safety and efficacy of trastuzumab administered as a 30-min infusion in patients with HER2-positive advanced gastric cancer

Oh, SY; Lee, S; Huh, SJ; Lee, J; Kim, ST; Park, SH; Lim, HY; Kang, WK; Kang, BW; Kim, JG; Lee, HJ; Kim, JH; Kang, JH; Kim, H

Kim, JG (reprint author), Kyungpook Natl Univ, Sch Med, Med Ctr, Dept Oncol Hematol, 807 Hoguk Ro, Daegu 41404, South Korea.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019; 83 (3): 501